<DOC>
	<DOCNO>NCT01864356</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability multiple dose subcutaneous NT100 v placebo follow vitro fertilization ( IVF ) woman history repeat IVF failure .</brief_summary>
	<brief_title>A Multi-Center Study To Evaluate Multiple Doses NT100 Following IVF In Women With Repeated IVF Failures ( Thrive-IVF )</brief_title>
	<detailed_description>NT-03 randomize , double blind , multi-center , placebo control study multiple dose subcutaneous NT100 follow IVF woman history repeat IVF failure . Approximately 150 subject randomize 1:1:1 ratio receive subcutaneous NT100 low dose , NT100 high dose , placebo , qd 4 week . Screening include standard IVF stimulation protocol , follow fertilization culture embryo . If subject remain eligible , randomized receive study drug . All subject follow 4 week last dose study drug . At Week 10 gestation , subject pregnant roll follow-up study ( NT-04 ) ass subsequent pregnancy , delivery , neonatal outcome .</detailed_description>
	<criteria>Premenopausal female 2138 year age screen History repeat IVF failure despite transfer goodquality embryo , define follow : ... 1 ) 3 IVF cycle involve transfer least two goodquality cleavagestage embryos least one goodquality blastocyst ( 2010 SART ( Society Assisted Reproductive Technologies ) grade criterion ) result one follow outcome : * ... ..a ) pregnancy * ... ..b ) biochemical pregnancy * ... ..c ) spontaneous abortion intrauterine clinical pregnancy equal complete Week 8 gestation ... 2 ) At least two eligible IVF failure must involve transfer fresh embryo ... 3 ) At least two eligible IVF failure must involve retrieval least 5 oocyte ... 4 ) No live birth , abortion later Week 8 gestation , stillbirth may occur since first IVF failure Body mass index ( BMI ) 1938 kg per m2 screen TSH ( thyroidstimulating hormone ) less equal 4.0 mIU/L ( milliInternational unit per Liter ) subject history hypothyroidism , TSH le equal 2.5 mIU/L subject history hypothyroidism , screen Prior diagnosis moderate severe ovarian hyperstimulation syndrome ( OHSS ) Clinically confirm polycystic ovary syndrome ( PCOS ) History major congenital anomaly subject , current male partner , first degree relative either subject current male partner Known karyotype abnormality either subject current male partner / sperm donor Any prior pregnancy terminate fetal medical condition History severe ( stage IV ) endometriosis Current past systemic autoimmune disease Any uncontrolled clinically significant medical condition ( e.g . asthma , Type II diabetes , infection )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>IVF failure</keyword>
	<keyword>Repeated IVF failure</keyword>
	<keyword>Implantation failure</keyword>
	<keyword>Repeated implantation failure</keyword>
	<keyword>IVF</keyword>
	<keyword>NT100</keyword>
</DOC>